Original scientific paper ЛИПИДНИОТ МАРКЕР АПОЛИПОПРОТЕИН Б КАКО ПРЕДИКТОР ЗА КОРОНАРНАТА АРТЕРИСКА БОЛЕСТ КАЈ ДИЈАБЕТЕС МЕЛИТУС ТИП 2 ПАЦИЕНТИ СО И БЕЗ ДИЈАБЕТИЧНА НЕФРОПАТИЈА
Вера Пеншовска Николова, Христијан Николов, Оливер С Георгиевски, Сефедин Биљали, Светлана Цековска, Жаклина Трајковска- Анчевска, Никола Оровчанец, PhD, Wels, Austria Atilla Rexhepi, Valon Asani, Fisnik Demiri, Vlora Ibrahimi, Amela Dobjani, Majlinda Ademi Profesional, Angjela Debreshlioska, Irfan Ismaili, Irina Angelovska, Venco Vuinov, Marija Karakostova, Ibadete Bucalija, Isjanovski Igor, Valza Ismajli, Veron Ismajli, Lidija Ristovska, Zora Jachova, Ilber Besimi, MD Bekim Ismaili, Rron Elezi, Katarina Vidoevska, Nagip Rufati, Besim Zeqiri, Valentina Simonovska, Lenče Miloševa, Ajla Shabani, Viktorija Jovanovska, Aleksandra Boshku, Nezhla Sh, Nikola Islami, Orovchanec, MD, Macedonia Ankica Pop-Kostova, Tatjana Ruskovska, Rozeta Shahinaj, Белакапоска Српанова, Арјета Рауфи, Крстевска Марина, Авди Константинова, Муртезани, Љиндита Џемаили Јакупи, Николовска Мимоза, Aртон Котевска, Нусрет Јакупи, Башким Исуфи, Османи, Ѓошевска Даштевска, Gazmend Mehmeti, Vesna Cheleva, Jana Nivicka Kjaeva, Hristian Duma, Наим Скендери, Бети Зафирова-Ивановскa, Арта Хисени Скендери, Марта Тунџева, Катарина Ставриќ, Кондова Ирена, Катерина Топузовска, Беким Ковачевиќ, Исмаили, Гициќ Азра, Ковачевиќ Катарина, Ангелеска Ружица, Сашка Јаневска, Danilo Nonkulovski, Ljelja Muaremoska-Kanzoska, Teodora Spasovska, Ilija Kirovski, Natasha Damjanovska, Ljubica Proeska Stojanovski, Katerina Grabuloska, Shkelqim Muharremi, Arlind Sejdini, Selami Zhaku, Jetmir Ziba, Gjulsen Selim, Teuta Dalipi, Rezeart Dalipi, Danica Popovska, MD Rexhep Selmani, Vladimir Joksimovic, Fesih Shehu, Fatjona Mislimi, Arian Selmani, Jovanovska Stojovska, Stojkovski A Medicus, Valza Ismajli, Veron Ismajli, MD Omer Dzemaili, PhD, Zurich, Switzerland Florin Ramadani, PhD, Tetovo, Macedonia Lul Raka, PhD, Prishtina, Kosova Nevzat Elezi, Nobel Laureate, MD Ferid Murad, PhD, Houston, USA Rifat Latifi, PhD, Arizona, USA Alex Leventa, Edirne, Turkiye Israel Sedat Ustundağ, MD Avdyl Krasniqi, PhD, Prishtina, Kosova Kirk Milhoan, PhD, Texas, USA Minir Hasani, PhD, Germany Alfred Priftanji, PhD, Tirana Albania Naser Ramadani, PhD, Prishtina, Kosova Yovcho Yovchev, PhD Stara Zagora, MD Bulgaria Skender Saiti, PhD, Skopje, Macedonia Milka Zdravkovska, PhD, Skopje, Macedonia Gentian Vyshka, PhD, Tirana Albania Gani Karamanaga, MD, Ulcinj, Montenegro Ramush Bejiqi, PhD, Prishtina, Kosova Meral Rexhepi, PhD, Tetovo, Macedonia Irfan Ahmeti, MD Shpetim Telegrafi, PhD New York, USA Gezim Bocari, PhD, Tirana, Albania Donco Donev, PhD, Skopje, Macedonia Isuf Dedushaj, PhD, Prishtina, Kosova Ramadan Jashari, PhD, Belgjum Holger Tietzt, PhD, Germany Vjollca Meka-Sahatciu, MD, PhD Milena Petrovska, PhD, Skopje, Macedonia Sonja Bojadzieva, PhD, Skopje, Macedonia Ylbert Ademi, MD, Gostivar, Macedonia Naser Durmishi, PhD Macedonia Sead Zeynel, MD, Macedonia Rihan Saiti
Background: Patients with COVID-19 can develop abnormal inflammatory response, which can progress to multiorgan failure and death, with a higher prevalence observed in men. Besides, recent research suggests a complex interaction between viral infections and vitamin D. Aims: This study evaluates sex differences of vitamin D status, circulating enzymes and biomarkers of inflammatory response at the time of diagnosis of COVID-19, depending on severity of disease the patients develop. Methods: This retrospective observational study was conducted from September to December 2020. Patients (n = 115) were divided in two groups: Group A-asymptomatic or mild cases (36 men and 19 women; mean age 53.3 ± 1.4 y.) and Group B-patients who develop moderate or severe COVID-19 requiring hospitalization (38 men and 22 women; mean age 56.1 ± 1.3 y.). Results: Patients of Group B had almost two-fold lower circulating 25(OH)D concentrations than patients of Group A (Group A: 61.6 ± 1.9 nmol/L; Group B: 32.2 ± 1.4 nmol/L; p < 0.001). Within Group A, the only parameter with a statistically significant sex difference was ferritin (p < 0.01). Within Group B, in addition to ferritin (p < 0.05), we observed a pronounced and statistically highly significant sex difference in circulating 25(OH)D concentrations (men: 35.8 ± 1.7 nmol/L; women: 26.0 ± 1.7; p < 0.001). Conclusions: Our results demonstrate that inadequate vitamin D status is associated with the development of moderate or severe COVID-19 and indicate that circulating 25(OH)D might be associated to sex differences in disease outcome.
VITAMIN D STATUS IN PATIENTS WITH COVID-19 -SEX DIFFERENCES ASSOCIATED WITH SEVERITY OF THE DISEASE.
Conflict of interest The authors declare that they have no conflict of interest.
References
Arsenault, Gage, Kim, Kapoor, Akweongo et al., COVID-19 and resilience of healthcare systems in ten countries, Nat Med,
doi:10.1038/s41591-022-01750-Aslan, Aslan, Özdemir, Letter to the Editor: Is Vitamin D One of the Key Elements in COVID-19 Days?, J Nutr Health Aging,
doi:10.1007/s12603-020-1413-5Autier, Mullie, Macacu, Dragomir, Boniol et al., Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials, Lancet Diabetes Endocrinol,
doi:10.1016/s2213-8587(17)30357-1Ben-Eltriki, Hopefl, Wright, Association between Vitamin D Status and Risk of Developing Severe COVID-19 Infection: A Meta-Analysis of Observational Studies, J Am Nutr Assoc,
doi:10.1080/07315724.2021.1951891Chiodini, Gatti, Soranna, Merlotti, Mingiano et al., Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes, Front Public Health,
doi:10.3389/fpubh.2021.736665Correale, Ysrraelit, Gaitán, Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects, J Immunol,
doi:10.4049/jimmunol.1000588Cullis, Fitzsimons, Griffiths, Tsochatzis, Thomas, Investigation and management of a raised serum ferritin, Br J Haematol,
doi:10.1111/bjh.15166Dror, Morozov, Daoud, Namir, Yakir et al., Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness, PLoS One,
doi:10.1371/journal.pone.0263069Gandini, Criniti, Gagliardi, Ballesio, Giglio et al., Sexdisaggregated data confirm serum ferritin as an independent predictor of disease severity both in male and female COVID-19 patients, J Infect,
doi:10.1016/j.jinf.2020.10.012Getachew, Tizabi, Vitamin D and COVID-19: Role of ACE2, age, gender, and ethnicity, J Med Virol,
doi:10.1002/jmv.27075Grant, Lahore, Mcdonnell, Baggerly, French et al., Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths, Nutrients,
doi:10.3390/nu12040988Hamid, Abid, Amir, Rehman, Akram et al., Current burden on healthcare systems in low-and middle-income countries: recommendations for emergency care of COVID-19, Drugs Ther Perspect,
doi:10.1007/s40267-020-00766-2Hars, Mendes, Serratrice, Herrmann, Gold et al., Sex-specific association between vitamin D deficiency and COVID-19 mortality in older patients, Osteoporos Int,
doi:10.1007/s00198-020-05677-6Hopefl, Ben-Eltriki, Association Between Vitamin D Levels and Inflammatory Markers in COVID-19 Patients: A Meta-Analysis of Observational Studies, J Pharm Pharm Sci,
doi:10.18433/jpps32518Jain, Chaurasia, Sengar, Singh, Mahor et al., Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers, Sci Rep,
doi:10.1038/s41598-020-77093-zJakovac, COVID-19 and vitamin D-Is there a link and an opportunity for intervention?, Am J Physiol Endocrinol Metab,
doi:10.1152/ajpen-do.00138Kato, Kurzrock, Repurposing Interleukin-6 Inhibitors to Combat COVID-19, J Immunother Precis Oncol,
doi:10.36401/jipo-20-11Kaushal, Kaur, Sarma, Bhattacharyya, Sharma et al., Serum ferritin as a predictive biomarker in COVID-19. A systematic review, meta-analysis and meta-regression analysis, J Crit Care,
doi:10.1016/j.jcrc.2021.09.023Laird, Rhodes, Kenny, Vitamin D and Inflammation: Potential Implications for Severity of Covid-19, Ir Med J
Lundqvist, Norlin, Wikvall, 1α,25-Dihydroxyvitamin D3 exerts tissue-specific effects on estrogen and androgen metabolism, Biochim Biophys Acta,
doi:10.1016/j.bba-lip.2011.01.004Martineau, Jolliffe, Hooper, Greenberg, Aloia et al., Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data, Bmj,
doi:10.1136/bmj.i6583Mendelsohn, Protective effects of estrogen on the cardiovascular system, Am J Cardiol
Mjaess, Karam, Aoun, Albisinni, Roumeguère, COVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptor, Prog Urol,
doi:10.1016/j.purol.2020.05.007Mogharab, Ostovar, Ruszkowski, Hussain, Shrestha et al., Global burden of the COVID-19 associated patient-related delay in emergency healthcare: a panel of systematic review and meta-analyses, Global Health,
doi:10.1186/s12992-022-00836-2Pagano, Peruzzu, Ruggieri, Ortona, Gagliardi, None
Peckham, De Gruijter, Raine, Radziszewska, Ciurtin et al., Male sex identified by global COVID-19 metaanalysis as a risk factor for death and ITU admission, Nat Commun,
doi:10.1038/s41467-020-19741-6Pop-Kostova, Ruskovska, Clinical significance of circulating enzymes in patients with COVID-19, Knowledge -International Journal
Pop-Kostova, Ruskovska, Inflammatory biomarkers in patients with COVID-19, Knowledge -International Journal
Prof, Omer Xhemaili, Zurich, Prof, Dr et al., None
Saponaro, Franzini, Okoye, Antognoli, Campi et al., Is There a Crucial Link Between Vitamin D Status and Inflammatory Response in Patients With COVID-19?, Front Immunol,
doi:10.3389/fimmu.2021.745713Spanier, Nashold, Mayne, Nelson, Hayes, Vitamin D and estrogen synergy in Vdr-expressing CD4(+) T cells is essential to induce Helios(+)FoxP3(+) T cells and prevent autoimmune demyelinating disease, J Neuroimmunol,
doi:10.1016/j.jneuroim.2015.06.015Takase, Tsugawa, Sugiyama, Ikesue, Eto et al., Association between 25-hydroxyvitamin D levels and COVID-19 severity, Clin Nutr ESPEN,
doi:10.1016/j.clne-sp.2022.04.003Teymoori-Rad, Shokri, Salimi, Marashi, The interplay between vitamin D and viral infections, Rev Med Virol,
doi:10.1002/rmv.2032
